211 related articles for article (PubMed ID: 26994815)
41. [Chronic meningococcemia caused by Neisseria meningitidis of serogroup C].
Suriñach JM; Alegre J; García Patos V; Planes A; Fernández de Sevilla T
Enferm Infecc Microbiol Clin; 1995; 13(7):439-40. PubMed ID: 8519824
[No Abstract] [Full Text] [Related]
42. Isolation and characterization of Neisseria meningitidis in the vaccine era. Who needs what and when?
Olcén P; Fredlund H
Scand J Infect Dis; 2010; 42(1):4-11. PubMed ID: 19883161
[TBL] [Abstract][Full Text] [Related]
43. Purpura fulminans in a child due to Neisseria meningitidis.
Özdemir H; Kendirli T; Çiftçi E; Ince E
Infection; 2012 Dec; 40(6):717-8. PubMed ID: 22718363
[No Abstract] [Full Text] [Related]
44. Neisseria meningitidis W135 pneumonia with sepicaemia in a nonogenarian.
Cadwgan AM; MacKenzie AR; Laing RB
Scott Med J; 1998 Oct; 43(5):148. PubMed ID: 9854302
[TBL] [Abstract][Full Text] [Related]
45. Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab.
Parikh SR; Lucidarme J; Bingham C; Warwicker P; Goodship T; Borrow R; Ladhani SN
Pediatrics; 2017 Sep; 140(3):. PubMed ID: 28864711
[TBL] [Abstract][Full Text] [Related]
46. Fulminant meningococcal sepsis due to non-groupable Neisseria meningitidis in a patient receiving eculizumab.
Hall V; Pai Mangalore R; He S; Stevens K; Trubiano JA; Holmes NE; Howden BP; Kwong JC
Med J Aust; 2018 Jun; 208(11):478-479. PubMed ID: 29902403
[No Abstract] [Full Text] [Related]
47. Does post-implementation vaccine effectiveness data support pre-implementation predictions of 4CMenB utility?
Findlow J; Borrow R
Pathog Dis; 2017 Mar; 75(2):. PubMed ID: 28334397
[TBL] [Abstract][Full Text] [Related]
48. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Feb; 46(RR-5):1-10. PubMed ID: 9048846
[TBL] [Abstract][Full Text] [Related]
49. Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination.
Parikh SR; Campbell H; Beebeejaun K; Ribeiro S; Gray SJ; Borrow R; Ramsay ME; Ladhani SN
Emerg Infect Dis; 2016 Aug; 22(8):1505-7. PubMed ID: 27433852
[No Abstract] [Full Text] [Related]
50. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
[No Abstract] [Full Text] [Related]
51. Concerns about unapproved meningococcal vaccination for eculizumab therapy in Japan.
Tanimoto T; Kusumi E; Hosoda K; Kouno K; Hamaki T; Kami M
Orphanet J Rare Dis; 2014 Apr; 9():48. PubMed ID: 24716834
[TBL] [Abstract][Full Text] [Related]
52. Group-C meningococcal conjunctivitis in a neonate.
Dinakaran S; Desai SP
Ocul Immunol Inflamm; 2000 Jun; 8(2):123-5. PubMed ID: 10980686
[TBL] [Abstract][Full Text] [Related]
53. Meningococcal disease and prevention at the Hajj.
Borrow R
Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
[TBL] [Abstract][Full Text] [Related]
54. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
[TBL] [Abstract][Full Text] [Related]
55. Meningococcal protein antigens and vaccines.
Feavers IM; Pizza M
Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315
[TBL] [Abstract][Full Text] [Related]
56. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines.
Diggle MA; Clarke SC
J Clin Microbiol; 2005 Sep; 43(9):4649-53. PubMed ID: 16145121
[TBL] [Abstract][Full Text] [Related]
57. Evolving meningococcal immunization strategies.
Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
[TBL] [Abstract][Full Text] [Related]
58. First case of meningococcal meningitis due to Neisseria meningitidis serogroup Z' in Slovenia, December 2010.
Trop Skaza A; Selic Kurincic T; Beskovnik L; Paragi M; Bozanic V
Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329646
[TBL] [Abstract][Full Text] [Related]
59. Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.
Hou VC; Koeberling O; Welsch JA; Granoff DM
J Infect Dis; 2005 Aug; 192(4):580-90. PubMed ID: 16028126
[TBL] [Abstract][Full Text] [Related]
60. Risk of antibiotic resistant meningococcal infections in Hajj pilgrims.
Zumla A; Memish ZA
BMJ; 2019 Aug; 366():l5260. PubMed ID: 31444169
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
